銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Zim Laboratories
ZIMLAB ?NSE

Zim Laboratories

?116.002.03 (1.78%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
109.00
Today’s high
118.00
52 week low
59.31
52 week high
127.00
Open price
113.96
Previous close
113.97
Live volume
26,954
Lower circuit
108.28
Upper circuit
119.66

Fundamentals

Market Cap
?610Cr
ROE
1.97%
P/E Ratio(TTM)
104.59
EPS(TTM)
1.09
P/B Ratio
2.08
Dividend Yield
0.00%
Industry P/E
33.86
Book Value
54.86
Debt to Equity
0.42
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?111
+0.97%
Profit (Cr)
?3.74
-15.00%
-25025100225
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+1%
3Y CAGR-2%
Profit growthValue
1Y (TTM)-23%
3Y CAGR-38%

About

Established in 1989, ZIM Laboratories Limited is a research-focused Indian company recognized globally for its innovative drug delivery solutions and complex generic products. The company's vision is to make quality healthcare affordable and accessible through drug delivery systems that prioritize patient convenience and improve treatment adherence. It specializes in developing and manufacturing differentiated oral solid dosage forms using proprietary, non-infringing technologies and Novel Drug Delivery Techniques (NDDS). The business operates in two primary segments, with Pharmaceuticals contributing 75% of the total operating income in the fiscal year 2025. The Nutraceuticals division, which offers vitamins and dietary supplements, accounted for the other 25% of the company's operating income during the same period. To drive its innovation-led strategy, the company dedicated 8.8% of its total operating income to research and development activities in fiscal year 2025.;
CEO/MD
Dr. Anwar S.Daud
Founded in
1984
NSE symbol
ZIMLAB

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
69.58%
Promoters
30.34%
Other Domestic Institutions
0.07%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
?8,386.50
-142.50 (1.67%)
L
    H
    21,286.25113.5124.39
    PfizerPFIZER
    ?4,526.80
    -12.50 (0.28%)
    L
      H
      20,766.7328.744.94
      ?1,425.80
      -4.80 (0.34%)
      L
        H
        19,822.7430.615.08
        ?791.85
        +9.75 (1.25%)
        L
          H
          19,386.3932.583.81
          Livesquawk ?
          Zim Laboratories' Q4 EBITDA drops to ?72M from ?146M YoY. Q4 EBITDA margin declines to 6.8% from 13.4% YoY.
          2026
          19
          May
          Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          7
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com